Chondrocyte signaling and artificial matrices for articular cartilage engineering

Advances in Experimental Medicine and Biology

Volumn 585, Issue , 2006, Pages 67-86

  Yoon, Diana M ^a   Fisher, John P ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934437662     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-34133-0_5     Document Type: Conference Paper

References (117)

1. Poole, A.R. et al. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res, S26-33 (2001).
2. Ulrich-Vinther, M., Maloney, M.D., Schwarz, E.M., Rosier, R. & O'Keefe, R.J. Articular cartilage biology. J Am Acad Orthop Surg 11, 421-30 (2003).
3. Randolph, M.A., Anseth, K. & Yaremchuk, M.J. Tissue engineering of cartilage. Clin Plast Surg 30, 519-37 (2003).
4. Newman, A.P. Articular cartilage repair. Am J Sports Med 26, 309-24 (1998).
5. Almarza, A.J. & Athanasiou, K.A. Design characteristics for the tissue engineering of cartilaginous tissues. Ann Biomed Eng 32, 2-17 (2004).
6. Woodfield, T.B., Bezemer, J.M., Pieper, J.S., van Blitterswijk, C.A. & Riesle, J. Scaffolds for tissue engineering of cartilage. Crit Rev Eukaryot Gene Expr 12, 209-36 (2002).
7. Goessler, U.R., Hormann, K. & Riedel, F. Tissue engineering with chondrocytes and function of the extracellular matrix (Review). Int J Mol Med 13, 505-13 (2004).
8. Riesle, J., Hollander, A.P., Langer, R., Freed, L.E. & Vunjak-Novakovic, G. Collagen in tissue-engineered cartilage: types, structure, and crosslinks. J Cell Biochem 71, 313-27 (1998).
9. Temenoff, J.S. & Mikos, A.G. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 21, 431-40 (2000).
10. Ishida, O., Tanaka, Y., Morimoto, I., Takigawa, M. & Eto, S. Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway. J Bone Miner Res 12, 1657-63 (1997).
11. van der Kraan, P.M., Buma, P., van Kuppevelt, T. & van den Berg, W.B. Interaction of chondrocytes, extracellular matrix and growth factors: relevance for articular cartilage tissue engineering. Osteoarthritis Cartilage 10, 631-7 (2002).
12. Holland, T.A. & Mikos, A.G. Advances in drug delivery for articular cartilage. J Control Release 86, 1-14 (2003).
13. Chubinskaya, S. & Kuettner, K.E. Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol 35, 1323-40 (2003).
14. Darling, E.M. & Athanasiou, K.A. Growth factor impact on articular cartilage subpopulations. Cell Tissue Res, 1-11 (2005).
15. Hickey, D.G., Frenkel, S.R. & Di Cesare, P.E. Clinical applications of growth factors for articular cartilage repair. Am J Orthop 32, 70-6 (2003).
16. Hunter, T. Signaling - 2000 and beyond. Cell 100, 113-27 (2000).
17. Martin, G.S. Cell signaling and cancer. Cancer Cell 4, 167-74 (2003).
18. Dhanasekaran, N. Cell signaling: an overview. Oncogene 17, 1329-30 (1998).
19. Brumley, L.M. & Marchase, R.B. Receptor synthesis and routing to the plasma membrane. Am J Med Sci 302, 238-43 (1991).
20. Geiger, B., Bershadsky, A., Pankov, R. & Yamada, K.M. Transmembrane crosstalk between the extracellular matrix - cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2, 793-805 (2001).
21. Lotz, M. Cytokines in cartilage injury and repair. Clin Orthop Relat Res, S108-15 (2001).
22. Hering, T.M. Regulation of chondrocyte gene expression. Front Biosci 4, D743-61 (1999).
23. Lee, J.W., Qi, W.N. & Scully, S.P. The involvement of beta1 integrin in the modulation by collagen of chondrocyte-response to transforming growth factor-beta1. J Orthop Res 20, 66-75 (2002).
24. Loeser, R.F. Integrins and cell signaling in chondrocytes. Biorheology 39, 119-24 (2002).
25. Loeser, R.F., Carlson, C.S. & McGee, M.P. Expression of beta 1 integrins by cultured articular chondrocytes and in osteoarthritic cartilage. Exp Cell Res 217, 248-57 (1995).
26. Glowacki, J., Trepman, E. & Folkman, J. Cell shape and phenotypic expression in chondrocytes. Proc Soc Exp Biol Med 172, 93-8 (1983).
27. Salter, D.M., Hughes, D.E., Simpson, R. & Gardner, D.L. Integrin expression by human articular chondrocytes. Br J Rheumatol 31, 231-4 (1992).
28. Enomoto, M., Leboy, P.S., Menko, A.S. & Boettiger, D. Beta 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin. Exp Cell Res 205, 276-85 (1993).
29. Kurtis, M.S. et al. Mechanisms of chondrocyte adhesion to cartilage: role of beta1-integrins, CD44, and annexin V. J Orthop Res 19, 1122-30 (2001).
30. Cao, L. et al. beta-Integrin-collagen interaction reduces chondrocyte apoptosis. Matrix Biol 18, 343-55 (1999).
31. Shakibaei, M., John, T., De Souza, P., Rahmanzadeh, R. & Merker, H.J. Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor. Biochem J 342 Pt 3, 615-23 (1999).
32. Curtis, A.J., Ng, C.K., Handley, C.J. & Robinson, H.C. Effect of insulin-like growth factor-I on the synthesis and distribution of link protein and hyaluronan in explant cultures of articular cartilage. Biochim Biophys Acta 1135, 309-17 (1992).
33. Blunk, T. et al. Differential effects of growth factors on tissue-engineered cartilage. Tissue Eng 8, 73-84 (2002).
34. Bhakta, N.R., Garcia, A.M., Frank, E.H., Grodzinsky, A.J. & Morales, T.I. The insulin-like growth factors (IGFs) I and II bind to articular cartilage via the IGF-binding proteins. J Biol Chem 275, 5860-6 (2000).
35. Wang, J., Elewaut, D., Veys, E.M. & Verbruggen, G. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage. Arthritis Rheum 48, 1281-91 (2003).
36. Morales, T.I. The role and content of endogenous insulin-like growth factor-binding proteins in bovine articular cartilage. Arch Biochem Biophys 343, 164-72 (1997).
37. Claeys, I. et al. Insulin-related peptides and their conserved signal transduction pathway. Peptides 23, 807-16 (2002).
38. Bunn, R.C. & Fowlkes, J.L. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 14, 176-81 (2003).
39. Dupont, J., Dunn, S.E., Barrett, J.C. & LeRoith, D. Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression. Recent Prog Horm Res 58, 325-42 (2003).
40. Dupont, J. & Holzenberger, M. Biology of insulin-like growth factors in development. Birth Defects Res C Embryo Today 69, 257-71 (2003).
41. Nakajima, H., Goto, T., Horikawa, O., Kikuchi, T. & Shinmei, M. Characterization of the cells in the repair tissue of full-thickness articular cartilage defects. Histochem Cell Biol 109, 331-8 (1998).
42. Jones, J.I. & Clemmons, D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16, 3-34 (1995).
43. Matsumoto, T., Gargosky, S.E., Iwasaki, K. & Rosenfeld, R.G. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 81, 150-5 (1996).
44. Clemmons, D.R. IGF binding proteins: regulation of cellular actions. Growth Regul 2, 80-7 (1992).
45. Morales, T.I. The insulin-like growth factor binding proteins in uncultured human cartilage: increases in insulin-like growth factor binding protein 3 during osteoarthritis. Arthritis Rheum 46, 2358-67 (2002).
46. Malemud, C.J. Cytokines as therapeutic targets for osteoarthritis. BioDrugs 18, 23-35 (2004).
47. Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T. & Miyazono, K. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7, 1191-204 (2002).
48. Zimmerman, C.M. & Padgett, R.W. Transforming growth factor beta signaling mediators and modulators. Gene 249, 17-30 (2000).
49. Heldin, C.H., Miyazono, K. & ten Dijke, P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-71 (1997).
50. Balemans, W. & Van Hul, W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250, 231-50 (2002).
51. Reddi, A.H. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 83-A Suppl 1, S1-6 (2001).
52. Reddi, A.H. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN. Arthritis Res 3, 1-5 (2001).
53. Miyazono, K. Positive and negative regulation of TGF-beta signaling. J Cell Sci 113 ( Pt 7), 1101-9 (2000).
54. Miyazono, K., Kusanagi, K. & Inoue, H. Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 187, 265-76 (2001).
55. Li, T.F., O'Keefe, R.J. & Chen, D. TGF-beta signaling in chondrocytes. Front Biosci 10, 681-8 (2005).
56. van Beuningen, H.M., van der Kraan, P.M., Arntz, O.J. & van den Berg, W.B. Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 52, 185-91 (1993).
57. Qi, W.N. & Scully, S.P. Effect of type II collagen in chondrocyte response to TGF-beta 1 regulation. Exp Cell Res 241, 142-50 (1998).
58. Pedrozo, H.A. et al. Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1. J Cell Physiol 177, 343-54 (1998).
59. Hynes, R.O. Cell adhesion: old and new questions. Trends Cell Biol 9, M33-7 (1999).
60. Morales, T.I. Transforming growth factor-beta 1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch Biochem Biophys 286, 99-106 (1991).
61. Guerne, P.A., Sublet, A. & Lotz, M. Growth factor responsiveness of human articular chondrocytes: distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts. J Cell Physiol 158, 476-84 (1994).
62. Bitzer, M. et al. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev 14, 187-97 (2000).
63. Schneiderbauer, M.M., Dutton, C.M. & Scully, S.P. Signaling "cross-talk" between TGF-beta1 and ECM signals in chondrocytic cells. Cell Signal 16, 1133-40 (2004).
64. Cook, S.D., Barrack, R.L., Patron, L.P. & Salkeld, S.L. Osteogenic protein-1 in knee arthritis and arthroplasty. Clin Orthop Relat Res, 140-5 (2004).
65. Luyten, F.P. et al. Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures. J Biol Chem 267, 3691-5 (1992).
66. Reddi, A.H. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng 6, 351-9 (2000).
67. Brunet, L.J., McMahon, J.A., McMahon, A.P. & Harland, R.M. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280, 1455-7 (1998).
68. Frenkel, S.R. et al. Transforming growth factor beta superfamily members: role in cartilage modeling. Plast Reconstr Surg 105, 980-90 (2000).
69. Nishida, Y., Knudson, C.B., Kuettner, K.E. & Knudson, W. Osteogenic protein-1 promotes the synthesis and retention of extracellular matrix within bovine articular cartilage and chondrocyte cultures. Osteoarthritis Cartilage 8, 127-36 (2000).
70. Vinall, R.L., Lo, S.H. & Reddi, A.H. Regulation of articular chondrocyte phenotype by bone morphogenetic protein 7, interleukin 1, and cellular context is dependent on the cytoskeleton. Exp Cell Res 272, 32-44 (2002).
71. Lietman, S.A., Yanagishita, M., Sampath, T.K. & Reddi, A.H. Stimulation of proteoglycan synthesis in explants of porcine articular cartilage by recombinant osteogenic protein-1 (bone morphogenetic protein-7). J Bone Joint Surg Am 79, 1132-7 (1997).
72. Heldin, C.H. Platelet-derived growth factor - an introduction. Cytokine Growth Factor Rev 15, 195-6 (2004).
73. Betsholtz, C. Biology of platelet-derived growth factors in development. Birth Defects Res C Embryo Today 69, 272-85 (2003).
74. Schafer, S.J., Luyten, F.P., Yanagishita, M. & Reddi, A.H. Proteoglycan metabolism is age related and modulated by isoforms of platelet-derived growth factor in bovine articular cartilage explant cultures. Arch Biochem Biophys 302, 431-8 (1993).
75. Harvey, A.K., Stack, S.T. & Chandrasekhar, S. Differential modulation of degradative and repair responses of interleukin-1-treated chondrocytes by platelet-derived growth factor. Biochem J 292 ( Pt 1), 129-36 (1993).
76. Sah, R.L., Chen, A.C., Grodzinsky, A.J. & Trippel, S.B. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. Arch Biochem Biophys 308, 137-47 (1994).
77. Chin, J.E., Hatfield, C.A., Krzesicki, R.F. & Herblin, W.F. Interactions between interleukin-1 and basic fibroblast growth factor on articular chondrocytes. Effects on cell growth, prostanoid production, and receptor modulation. Arthritis Rheum 34, 314-24 (1991).
78. Klooster, A.R. & Bernier, S.M. Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Res Ther 7, R127-38 (2005).
79. Huh, Y.H., Kim, S.H., Kim, S.J. & Chun, J.S. Differentiation status-dependent regulation of cyclooxygenase-2 expression and prostaglandin E2 production by epidermal growth factor via mitogenactivated protein kinase in articular chondrocytes. J Biol Chem 278, 9691-7 (2003).
80. Enomoto, H. et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 162, 171-81 (2003).
81. Pufe, T., Petersen, W., Tillmann, B. & Mentlein, R. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44, 1082-8 (2001).
82. Neufeld, G., Cohen, T., Gengrinovitch, S. & Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 13, 9-22 (1999).
83. Pulsatelli, L. et al. Vascular endothelial growth factor activities on osteoarthritic chondrocytes. Clin Exp Rheumatol 23, 487-93 (2005).
84. Pfander, D. et al. Hepatocyte growth factor in human osteoarthritic cartilage. Osteoarthritis Cartilage 7, 548-59 (1999).
85. Moo, V., Sieper, J., Herzog, V. & Muller, B.M. Regulation of expression of cytokines and growth factors in osteoarthritic cartilage explants. Clin Rheumatol 20, 353-8 (2001).
86. Attur, M.G., Dave, M., Akamatsu, M., Katoh, M. & Amin, A.R. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 10, 1-4 (2002).
87. Pfander, D., Heinz, N., Rothe, P., Carl, H.D. & Swoboda, B. Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1beta: a possible explanation for the changes in matrix synthesis during osteoarthritis. Ann Rheum Dis 63, 240-4 (2004).
88. Stabellini, G. et al. Effects of interleukin-1beta on chondroblast viability and extracellular matrix changes in bovine articular cartilage explants. Biomed Pharmacother 57, 314-9 (2003).
89. Vosshenrich, C.A. & Di Santo, J.P. Interleukin signaling. Curr Biol 12, R760-3 (2002).
90. Legendre, F., Dudhia, J., Pujol, J.P. & Bogdanowicz, P. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. J Biol Chem 278, 2903-12 (2003).
91. Blanco, F.J., Ochs, R.L., Schwarz, H. & Lotz, M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146, 75-85 (1995).
92. Olee, T., Hashimoto, S., Quach, J. & Lotz, M. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 162, 1096-100 (1999).
93. Seguin, C.A. & Bernier, S.M. TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways. J Cell Physiol 197, 356-69 (2003).
94. Malemud, C.J. Fundamental pathways in osteoarthritis: an overview. Front Biosci 4, D659-61 (1999).
95. Wajant, H., Pfizenmaier, K. & Scheurich, P. Tumor necrosis factor signaling. Cell Death Differ 10, 45-65 (2003).
96. Baud, V. & Karin, M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11, 372-7 (2001).
97. Scherle, P.A., Pratta, M.A., Feeser, W.S., Tancula, E.J. & Arner, E.C. The effects of IL-1 on mitogen-activated protein kinases in rabbit articular chondrocytes. Biochem Biophys Res Commun 230, 573-7 (1997).
98. Olney, R.C., Wilson, D.M., Mohtai, M., Fielder, P.J. & Smith, R.L. Interleukin-1 and tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J Endocrinol 146, 279-86 (1995).
99. Hoffman, A.S. Hydrogels for biomedical applications. Adv Drug Deliv Rev 54, 3-12 (2002).
100. Lee, K.Y. & Mooney, D.J. Hydrogels for tissue engineering. Chem Rev 101, 1869-79 (2001).
101. Gutowska, A., Jeong, B. & Jasionowski, M. Injectable gels for tissue engineering. Anat Rec 263, 342-9 (2001).
102. Benya, P.D. & Shaffer, J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215-24 (1982).
103. Elisseeff, J.H., Lee, A., Kleinman, H.K. & Yamada, Y. Biological response of chondrocytes to hydrogels. Ann N Y Acad Sci 961, 118-22 (2002).
104. Alsberg, E., Anderson, K.W., Albeiruti, A., Rowley, J.A. & Mooney, D.J. Engineering growing tissues. Proc Natl Acad Sci U S A 99, 12025-30 (2002).
105. Grunder, T. et al. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage 12, 559-67 (2004).
106. Chubinskaya, S. et al. Gene expression by human articular chondrocytes cultured in alginate beads. J Histochem Cytochem 49, 1211-20 (2001).
107. Starkman, B.G., Cravero, J.D., Delcarlo, M. & Loeser, R.F. IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK. Biochem J 389, 723-9 (2005).
108. Almqvist, K.F. et al. Culture of chondrocytes in alginate surrounded by fibrin gel: characteristics of the cells over a period of eight weeks. Ann Rheum Dis 60, 781-90 (2001).
109. Perka, C., Spitzer, R.S., Lindenhayn, K., Sittinger, M. & Schultz, O. Matrix-mixed culture: new methodology for chondrocyte culture and preparation of cartilage transplants. J Biomed Mater Res 49, 305-11 (2000).
110. Qi, W.N. & Scully, S.P. Type II collagen modulates the composition of extracellular matrix synthesized by articular chondrocytes. J Orthop Res 21, 282-9 (2003).
111. Flechtenmacher, J. et al. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 39, 1896-904 (1996).
112. Clancy, R.M. et al. Outside-in signaling in the chondrocyte. Nitric oxide disrupts fibronectin-induced assembly of a subplasmalemmal actin/rho A/focal adhesion kinase signaling complex. J Clin Invest 100, 1789-96 (1997).
113. Girotto, D. et al. Tissue-specific gene expression in chondrocytes grown on three-dimensional hyaluronic acid scaffolds. Biomaterials 24, 3265-75 (2003).
114. Miralles, G. et al. Sodium alginate sponges with or without sodium hyaluronate: in vitro engineering of cartilage. J Biomed Mater Res 57, 268-78 (2001).
115. Elisseeff, J., McIntosh, W., Fu, K., Blunk, B.T. & Langer, R. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 19, 1098-104 (2001).
116. Fisher, J.P., Jo, S., Mikos, A.G. & Reddi, A.H. Thermoreversible hydrogel scaffolds for articular cartilage engineering. J Biomed Mater Res A 71, 268-74 (2004).
117. Park, Y., Lutolf, M.P., Hubbell, J.A., Hunziker, E.B. & Wong, M. Bovine primary chondrocyte culture in synthetic matrix metalloproteinase- sensitive poly(ethylene glycol)-based hydrogels as a scaffold for cartilage repair. Tissue Eng 10, 515-22 (2004).